Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks

医学 危险系数 痴呆 内科学 队列 回顾性队列研究 2型糖尿病 二甲双胍 队列研究 倾向得分匹配 相对风险 糖尿病 置信区间 内分泌学 胰岛素 疾病
作者
Yen‐Wei Pai,I‐Chieh Chen,Jun‐Fu Lin,Xiaohong Chen,Hsin‐Hua Chen,Ming‐Hong Chang,Jin‐An Huang,Ching‐Heng Lin
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
被引量:1
标识
DOI:10.1111/dom.15918
摘要

Abstract Background Limited evidence exists to support any specific medication over others to prevent dementia in older patients with type 2 diabetes (T2D). We investigated whether treatment with sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors is associated with a lower risk of incident dementia and all‐cause mortality, relative to dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA). Methods In this retrospective, active‐comparator cohort study, we used data from the TriNetX electronic health records network. Our primary cohort comprised patients with T2D aged ≥50 years, registered between January 2012 and December 2022. Patients with a history of dementia were excluded. We used Kaplan–Meier survival analysis to estimate the incidence of dementia and all‐cause mortality in our cohort after they had used glucose‐lowering drugs for at least 12 months. Propensity score matching was performed to balance the SGLT‐2 inhibitor, DPP‐4 inhibitor and GLP‐1 RA cohorts. Subgroup analyses for sex and age were also conducted. Results Our first cohort comprised 193 948 patients treated with metformin and SGLT‐2 inhibitors and an equal number of patients treated with metformin and DPP‐4 inhibitors. In this cohort, the risk of dementia and all‐cause mortality was lower in patients treated with SGLT‐2 inhibitors than in those treated with DPP‐4 inhibitors (hazard ratio [HR]: 0.62, 95% confidence interval [CI]: 0.59–0.65, for dementia; HR: 0.54, 95% CI: 0.52–0.56, for all‐cause mortality). Our second cohort comprised 165 566 patients treated with metformin and SGLT‐2 inhibitors and an equal number of patients treated with metformin and GLP‐1 RAs. In this cohort, the risk of dementia and all‐cause mortality was lower in those treated with SGLT‐2 inhibitors than in those treated with GLP‐1 RAs (HR: 0.92, 95% CI: 0.87–0.98, for dementia; HR: 0.88, 95% CI: 0.85–0.91, for all‐cause mortality). Conclusions The use of SGLT‐2 inhibitor was associated with a lower risk of incident dementia and all‐cause mortality in older adults with T2D compared to DPP‐4 inhibitor and GLP‐1 RA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
糊涂的山雁完成签到,获得积分10
刚刚
wenbin完成签到,获得积分10
1秒前
2秒前
3秒前
rgjipeng完成签到,获得积分10
4秒前
轻松绿旋完成签到,获得积分10
4秒前
5秒前
优雅山柏发布了新的文献求助10
5秒前
lxhhh完成签到,获得积分10
6秒前
火星上的雨莲完成签到,获得积分10
8秒前
CHANG完成签到 ,获得积分10
8秒前
严西完成签到,获得积分10
9秒前
小柚子完成签到,获得积分10
9秒前
萌萌完成签到 ,获得积分10
10秒前
Ryan完成签到,获得积分10
11秒前
12秒前
一条摆摆的沙丁鱼完成签到 ,获得积分10
12秒前
apocalypse完成签到 ,获得积分10
13秒前
djbj2022发布了新的文献求助10
15秒前
grace完成签到 ,获得积分10
16秒前
zpz完成签到,获得积分10
20秒前
墨墨完成签到 ,获得积分10
21秒前
CipherSage应助氮化硼小兵采纳,获得10
21秒前
Jieh完成签到,获得积分10
21秒前
科研孙完成签到,获得积分10
21秒前
小党完成签到,获得积分10
25秒前
优雅山柏完成签到,获得积分10
29秒前
xiaofenzi完成签到,获得积分10
31秒前
DOUBLE完成签到,获得积分10
32秒前
马超放烟花完成签到 ,获得积分10
32秒前
tivyg'lk完成签到,获得积分10
33秒前
Loong完成签到,获得积分10
33秒前
养花低手完成签到 ,获得积分10
34秒前
34秒前
yoyo完成签到,获得积分10
35秒前
在九月完成签到 ,获得积分10
41秒前
xudongmei完成签到,获得积分10
41秒前
小鱼儿完成签到 ,获得积分10
41秒前
完犊子完成签到,获得积分20
41秒前
背后的白山完成签到,获得积分10
42秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513393
关于积分的说明 11167478
捐赠科研通 3248836
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875131
科研通“疑难数据库(出版商)”最低求助积分说明 804664